CAS RN: 147403-65-4
(Z)-Methyl 2-ethoxy-3-((2′-(N’-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d] iMidazole-4-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20251104
250mg / 1g / 5g / 25g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 147403-65-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Shenzhen
Inquiry
147403-65-4 / methyl 2-ethoxy-3-[[4-[2-[(Z)-N'-hydroxycarbamimidoyl]phenyl]phenyl]methyl]benzimidazole-4-carboxylate
Standard CAS: 147403-65-4
Multi CAS: No
Basic Information
copy
CAS
147403-65-4 copy
Multi CAS
No copy
Molecular Formula
C25H24N4O4 copy
Molecular Weight
444.500000 copy
Exact Mass
444.179755 copy
SMILES
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4/C(=N/O)/N)C(=O)OC copy
InChI
InChI=1S/C25H24N4O4/c1-3-33-25-27-21-10-6-9-20(24(30)32-2)22(21)29(25)15-16-11-13-17(14-12-16)18-7-4-5-8-19(18)23(26)28-31/h4-14,31H,3,15H2,1-2H3,(H2,26,28) copy
InChIKey
OQJREYQHKLULTR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
33 copy
Aromatic heavy atom count
21 copy
Fraction Csp3
0.16 copy
Rotatable bonds
7 copy
H-bond acceptors
7 copy
H-bond donors
2 copy
Molar refractivity
125.73 copy
TPSA
111.96 copy
LogP / Solubility
WLOGP
4.03 copy
MLOGP
3.58 copy
XLogP3
4.3 copy
Consensus LogP
3.97 copy
Log S (ESOL)
-5.14 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.12 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-6.74 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.57 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website. copy